Detalhe da pesquisa
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med
; 389(8): 687-699, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486775
2.
Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.
Circ Res
; 130(4): 578-592, 2022 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175850
3.
Osteopontin Is an Integral Mediator of Cardiac Interstitial Fibrosis in Models of Human Immunodeficiency Virus Infection.
J Infect Dis
; 228(2): 122-132, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162508
4.
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Clin Infect Dis
; 76(11): 2010-2013, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825498
5.
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Clin Infect Dis
; 77(12): 1676-1686, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439633
6.
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Clin Infect Dis
; 76(2): 323-334, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101518
7.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 76(3): e613-e621, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975297
8.
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
J Infect Dis
; 226(10): 1809-1822, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535576
9.
Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency Virus.
J Infect Dis
; 226(10): 1823-1833, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856671
10.
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis
; 225(4): 603-607, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794178
11.
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Clin Infect Dis
; 75(7): 1154-1163, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165682
12.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis
; 75(8): 1324-1333, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235653
13.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
Clin Infect Dis
; 73(11): 2009-2022, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134131
14.
Cardiovascular Disease Risk Among Transgender People with HIV.
Curr HIV/AIDS Rep
; 18(5): 407-423, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626323
15.
Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach.
J Infect Dis
; 222(6): 929-939, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310273
16.
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus.
J Infect Dis
; 221(8): 1315-1320, 2020 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100122
17.
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S20-S30, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645159
18.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645160
19.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S8-S19, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645162
20.
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S63-S69, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645158